V
Viz
Health Tech & Medtech · San Francisco, United States · Founded 2016
AI-powered medical imaging analysis and care coordination MoreLess
Viz.ai is a healthcare technology company that has developed an AI-powered platform for intelligent care coordination, focusing on the rapid analysis of medical imaging. Founded in 2016, the company's mission was born from a personal experience of one of its founders and the professional frustration of another. Neurosurgeon Dr. Chris Mansi witnessed a patient's death due to preventable delays in care, which inspired him to find a better system. He teamed up with Dr. David Golan, a machine learning post-doc at Stanford who had personally experienced the challenges of a delayed stroke diagnosis. Together, they aimed to use AI to accelerate diagnosis and treatment for time-sensitive conditions.
The company's core offering, the Viz.ai One platform, uses a suite of FDA-cleared AI algorithms to analyze medical images like CT scans, EKGs, and echocardiograms in real-time. This enables the platform to automatically detect suspected diseases, such as strokes, pulmonary embolisms, aortic dissections, and aneurysms, and immediately alert the entire specialized care team via a HIPAA-compliant mobile application. This process dramatically reduces the time to diagnosis and intervention, streamlining communication and care pathways between hospitals and specialists.
Viz.ai operates on a subscription-based SaaS model, charging hospitals and health systems an annual fee. This model has proven successful, with the platform adopted by over 1,700 hospitals in the U.S. and Europe. The company also partners with pharmaceutical and medical device companies to help accelerate patient access to new therapies and support clinical trial recruitment. Having achieved a valuation of $1.2 billion in April 2022, Viz.ai has raised significant funding from investors including Tiger Global, Insight Partners, Kleiner Perkins, and GV (formerly Google Ventures).
Keywords: care coordination, medical imaging AI, stroke detection, disease detection, clinical workflow, health-tech, medical diagnostics, AI algorithms, pulmonary embolism, aortic dissection, neurovascular, cardiovascular, intelligent care, real-time alerts, HIPAA-compliant communication, hospital SaaS, clinical decision support, medical technology, healthcare AI
Talent graph
Viz's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Viz has talent and traffic
team presence
across markets
Patent intelligence
$14M patent portfolio · 6 active families
Where Viz concentrates vs peers
Each axis is a top-10 topic across Viz and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Viz
An AI-synthesized read of the highest-engagement posts about Viz on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Viz on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


















